ClinicalTrials.Veeva

Menu

The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients (MIX-ECMO)

S

Semmelweis University

Status

Not yet enrolling

Conditions

Extracorporeal Membrane Oxygenation Complication
Myocardial Failure
Echocardiography
Cardiogenic Shock
Mechanical Circulatory Support

Study type

Observational

Funder types

Other

Identifiers

NCT05838937
BMEÜ/4229- 1 /2022/EKU

Details and patient eligibility

About

Investigation of the potential prognostic role of non-invasive myocardial work in patients receiving veno-arterial extracorporeal membrane oxygenation therapy.

Full description

The study aims to examine the prognostic role of non-invasive myocardial work in veno-arterial extracorporeal membrane oxygenation therapy patients. Subjects with cardiogenic shock regardless of etiology will be enrolled 48-72 hours after the initiation of mechanical circulatory support. It is hypothesized that non-invasive myocardial work may be an independent prognosticator of the outcome.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older age
  • Severe cardiogenic shock requiring the initiation of VA-ECMO therapy
  • Stabile hemodynamic state and oxigenation with VA-ECMO and vasoactive support
  • Informed written consent (due to the nature of the study, from a legally eligible relative of the patient)

Exclusion criteria

  • Younger than 18 years of age
  • Unstable hemodynamic state or suboptimal oxigenation despite established VA-ECMO and vasoactive support
  • Severe neurological damage or confirmed brain death at the time of enrollment which squarely indicates therapy limitation and poor short-term outcome
  • Transesophageal echocardiography is contraindicated
  • Suboptimal echocardiographic window

Trial design

100 participants in 1 patient group

Investigation cohort
Description:
Cardiogenic shock patients from any cause receiving veno-arterial extracorporeal membrane oxygenation

Trial contacts and locations

1

Loading...

Central trial contact

Bálint K Lakatos, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems